Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment

Antivirals already on the market and expertise gained from the SARS and MERS outbreaks are gaining momentum as the most effective way to combat the coronavirus outbreak. SARS-CoV-2 has caused considerable mortality due to respiratory failure, highlighting the immediate need for successful therapies...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavda, Vivek P., Gajjar, Normi, Shah, Nirav, Dave, Divyang J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Masson SAS. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532500/
https://www.ncbi.nlm.nih.gov/pubmed/36575695
http://dx.doi.org/10.1016/j.ejmcr.2021.100013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532500/
https://www.ncbi.nlm.nih.gov/pubmed/36575695
http://dx.doi.org/10.1016/j.ejmcr.2021.100013

Ejemplares similares